{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:35:45Z","timestamp":1782488145322,"version":"3.54.5"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Antiretroviral therapies for HIV may cause systemic toxicities when coadministered with corticosteroids. Potential drug-drug interactions may occur, leading to iatrogenic Cushing syndrome or adrenal insufficiency. This article highlights the drug-drug interactions of antiretroviral therapies with corticosteroids. Practice implications are discussed.<\/jats:p>","DOI":"10.1097\/01.npr.0000798224.30305.d1","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T23:00:40Z","timestamp":1637622040000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Antiretroviral therapies and corticosteroids"],"prefix":"10.1097","volume":"46","author":[{"given":"Myriam Jean","family":"Cadet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R2-20250607","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2215\/CJN.02240218","article-title":"Clinical pharmacology in HIV therapy","volume":"14","author":"Atta","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"e25449","DOI":"10.1002\/jia2.25449","article-title":"The challenge of HIV treatment in an era of polypharmacy","volume":"23","author":"Back","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"R4-20250607","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/cpt.1393","article-title":"Contemporary drug-drug interactions in HIV treatment","volume":"105","author":"Devanathan","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"R6-20250607","article-title":"Pharmacokinetics","author":"Grogan","year":"2021"},{"issue":"2","key":"R7-20250607","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jsps.2016.07.002","article-title":"An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice","volume":"25","author":"Salahudeen","year":"2017","journal-title":"Saudi Pharm J"},{"issue":"17","key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s40265-018-1010-7","article-title":"Bictegravir\/emtricitabine\/tenofovir alafenamide: a review in HIV-1 infection","volume":"78","author":"Deeks","year":"2018","journal-title":"Drugs"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-802103-3.00006-7","article-title":"Clinical pharmacokinetics and drug interactions","author":"Saha","year":"2018","journal-title":"Pharmaceutical Medicine and Translational Clinical Research"},{"issue":"3","key":"R10-20250607","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/03602532.2018.1483401","article-title":"Human cytochrome P450 enzymes 5\u201351 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits","volume":"50","author":"Rendic","year":"2018","journal-title":"Drug Metab Rev"},{"issue":"8","key":"R11-20250607","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/psb.1599","article-title":"Administering steroids with HIV treatment-boosting agents","volume":"28","author":"Singh","year":"2017","journal-title":"Prescriber"},{"issue":"5","key":"R13-20250607","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/17425255.2019.1604685","article-title":"Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment","volume":"15","author":"Gong","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"R16-20250607","doi-asserted-by":"crossref","first-page":"e226912","DOI":"10.1136\/bcr-2018-226912","article-title":"Exogenous steroid-induced hypoadrenalism in a person living with HIV caused by a drug-drug interaction between cobicistat and intrabursal triamcinolone","volume":"11","author":"Makaram","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"6","key":"R17-20250607","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4187\/respcare.06314","article-title":"Clinical pharmacology of corticosteroids","volume":"63","author":"Williams","year":"2018","journal-title":"Respir Care"},{"issue":"6","key":"R18-20250607","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1097\/MJT.0000000000000740","article-title":"Choosing inhaled steroids in a patient with HIV: clinical dilemma","volume":"25","author":"Jolly","year":"2018","journal-title":"Am J Ther"},{"issue":"2","key":"R19-20250607","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11096-020-00995-5","article-title":"Hypothalamic-pituitary-adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients","volume":"42","author":"Besemer","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"R20-20250607","first-page":"A5707","article-title":"An unusual complication of inhaled corticosteroids in an HIV infected patient","volume":"195","author":"Ali","year":"2017","journal-title":"Am Thorac Soc"},{"issue":"4","key":"R21-20250607","first-page":"445","article-title":"Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat","volume":"27","author":"Monge","year":"2019","journal-title":"Infez Med"},{"issue":"5","key":"R22-20250607","doi-asserted-by":"crossref","first-page":"e233712","DOI":"10.1136\/bcr-2019-233712","article-title":"Iatrogenic Cushing syndrome and multifocal osteonecrosis caused by the interaction between inhaled fluticasone and ritonavir","volume":"13","author":"Figueiredo","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"11","key":"R24-20250607","doi-asserted-by":"crossref","first-page":"ofaa416","DOI":"10.1093\/ofid\/ofaa416","article-title":"Evolution of drug interactions with antiretroviral medication in people with HIV","volume":"7","author":"El Moussaoui","year":"2020","journal-title":"Open Forum Infect Dis"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000798224.30305.d1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T17:01:08Z","timestamp":1749315668000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000798224.30305.d1"}},"subtitle":["Drug-drug interactions"],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000798224.30305.d1","relation":{},"ISSN":["0361-1817"],"issn-type":[{"value":"0361-1817","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}